Cinemark Holdings, Inc. 2026 Q2 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2026, for Cinemark Holdings, Inc. ("Holdings") and its primary operating subsidiary, Cinemark USA, Inc. ("CUSA"). The company operates in the theatrical exhibition industry with theaters in the United States and 13 countries in Latin America. As of June 30, 2026, the company operated 495 theaters with 5,620 screens worldwide.
Key Financial Metrics (Six Months Ended June 30, 2026)
- Revenue: Total revenue was $1,729.5 million, a 16.8% increase year-over-year.
- Admissions: $851.4 million (49.2% of total revenue).
- Concessions: $688.5 million (39.8% of total revenue).
- Other: $189.6 million (11.0% of total revenue).
- Profitability:
- Operating Income: $256.5 million (14.8% margin), compared to $154.3 million in the prior year period.
- Net Income (Holdings): $135.0 million, compared to $56.1 million in the prior year period.
- Net Income Attributable to Holdings: $133.0 million.
- Diluted Earnings Per Share (EPS): $1.13, compared to $0.38 in the prior year period.
- Cash Flow:
- Net cash provided by operating activities: $339.7 million.
- Net cash used for investing activities: ($99.1 million), primarily due to capital expenditures.
- Net cash used for financing activities: ($80.7 million), driven by dividends and share repurchases.
- Liquidity and Debt:
- Cash and cash equivalents: $504.3 million (up from $344.3 million at year-end 2025).
- Total Long-Term Debt (net of current portion): $1,870.5 million.
- Consolidated Net Total Leverage Ratio: 1.93 to 1.00.
Material Changes vs. Prior Period
- Revenue Growth: Driven by a stronger film slate (including *The Super Mario Galaxy Movie*, *Toy Story 5*, and *Star Wars: The Mandalorian and Grogu*) and strategic pricing actions. U.S. attendance increased 11.7% and International attendance increased 4.1% year-over-year.
- Cost Management: Operating costs increased due to higher attendance and inflationary pressures, but operating margins improved significantly. Concession supplies expense as a percentage of concession revenue decreased to 18.1% (from 19.2% in 2025) due to pricing and sourcing initiatives.
- Interest Expense: Decreased to $66.0 million (from $77.9 million) due to the payoff of $460 million in Convertible Senior Notes in August 2025 and term loan repricing.
- Capital Expenditures: Increased to $99.3 million (from $52.2 million) to support theater enhancements and new builds.
Guidance, Outlook, and Risks
- Outlook: Management expects to fund capital expenditures and obligations through cash flow from operations and existing credit facilities. The company maintains a $300 million share repurchase program, with $199.7 million remaining available as of June 30, 2026.
- Dividends: Quarterly dividends of $0.09 per share were paid in Q1 and Q2 2026.
- Risks:
- IRS Audit: The company is under audit for tax years 2019 and 2020. The IRS proposed an adjustment with a potential balance sheet impact of $65.0 million; the company intends to vigorously defend its positions.
- Legal Proceedings: A class action lawsuit regarding the Fair and Accurate Credit Transactions Act was refiled in May 2026. Another lawsuit regarding beer cup labeling was settled and dismissed in March 2026.
- Market Risks: Exposure to foreign currency exchange rates (notably Argentina's hyper-inflationary status) and interest rate fluctuations on variable rate debt.
Investor Verification Checklist
- Verify the sustainability of the 16.8% revenue growth given the heavy reliance on specific blockbuster releases in the first half of 2026.
- Monitor the outcome of the ongoing IRS audit regarding the $65.0 million proposed tax adjustment.
- Review the impact of inflation on concession supply costs and labor wages in the second half of the year.
- Assess the company's ability to maintain its dividend and share repurchase program if box office performance normalizes.
- Check the status of the refiled class action lawsuit regarding credit transaction disclosures.